Three key papers presented at ASCO Plenary session. Patients with brain cancer, rectal cancer and surgically resected lung cancer, will be the beneficiaries of an unparalleled era of exciting research. And we're just on the cusp of even greater benefits to follow #ASCO2023

At GI cancer conf. in the US, meeting with colleagues from around the world. Hard not to be despondent about the very limited access to molecular testing in Australia. We are quickly falling behind the RoW and patients are missing out #AGITG

Very exciting to hear presentation at ASCO meeting in San Francisco of AGITG INTEGRATE study which showed improved survival with regorafenib in advanced gastric cancer. With patients and industry, we are finally starting to shift the bar in this disease #AGITG #ascogi23

Today is #WorldMentalHealthDay , and we want to acknowledge the bidirectional impact of cancer on mental health. By shining a spotlight on the connection between mental and physical health, we hope to mobilise collective action to make living with cancer more accommodating.

Today is World GIST Day. It's vital we take time to acknowledge the many patients and their families who have had to endure this rare cancer. We should also acknowledge the many clinicians and companies that have worked tirelessly to identify effective therapies #AGITG #SPHPM

Just back from ASCO. So good to be 'in the room where it happens'... Some exciting data although perhaps not the extent of breakthroughs of yesteryear... but make no mistake those times are coming at breakneck speed. Like our patients, we await with baited breath #ASCO

Wonderful to celebrate International Clinical Trials day yesterday. The ACTA Award ceremony highlighted the enormous contributions that clinical trials make to the health and wealth of society, only possible because of the commitment of so many people across the community #ACTA

Yesterday ACTA meet with pharma, State reps and CROs interested in improving clinical trials in Australia. Lots of great ideas were shared, many of which will help make the clinical trial sector a lot more efficient. Much to be done but we'll all be the better for for it. #ACTA

The SSGXXII trial has just opened for patient enrolment! Led by Prof John Zalcberg and A/Prof Sumitra Ananda, this trial will compare extending the standard 3 years of treatment for GIST patients to 5 years to prevent disease recurrence: gicancer.org.au/clinical-trial… NHMRC CTC

Fantastic to be part of CANFORUM panel around really putting the patient at the centre of all health care. Fundamental to making this a reality, is the health social contract that Govt.s must honour by ensuring their actions are focussed on the patient of today Rare Cancers Australia

Stephen Duckett has nailed it. Even with a universal health system, there are still inequities in health outcomes in Australia. Unvaccinated people should not have to pay for COVID related health expenses- health care is a right not a privilege #SPHPM ,The Conversation - Australia + New Zealand #GRATTAN

Listening to Chair of PBAC discuss models of HTA. Concerns about disinvestment need to be 'put to bed'. These can be best dealt with when new, high cost drugs are provided through CQRs. This process will be a win-win, for patients, Govt. and industry. #RCA

Prof. Ian Frazer has summarised the substantial contribution the MRFF has made to clinical trials in Australia. With the imminent evaluation of outcomes, it will be be critical to understand the 'return on investment' to help direct future strategies #ACTAASM21

Wonderful to be part of the plenary panel celebrating 30 year history of the Australasian Gastrointestinal Trials Group (AGITG). Whilst much has been achieved, with the depth of talent within the Group, and partnership with consumers the future is boundless #AGITG

MRFF Workshop on clinical trial innovations is a fantastic opportunity for the clinical trials sector to discuss the good,the bad & the ugly about clinical trials with the Department of Health. Through 'co-design' with funders, we can build a better health sector #ACTA

The beginning of a new era for future patients with pancreatic cancer as Cancer Australia Roadmap gets underway. Understanding the balance of many important priorities from prevention to end-of-life care to key research questions will be critical #NPCRoadmap

The AGITG #AGITG is discussing new ideas to improve outcomes for patients with primary liver cancer, an increasing cancer problem in Australia. A dedicated group of clinicians, scientists and consumers, over 75 people in total, all collaborating with a single focus. Inspiring !

ACTA Advisory Council considering really important strategic opportunities for how we work with the sector to improve health care through embedding research into day-to-day practice. Engagement is inspiring ACTA Australian Clinical Trials Alliance

#Personcentred care webinar highlights the fact that rationing access to drugs is alive and well in Australia. We have to do better and allow interim access to novel treatments for patients if PBAC is uncertain of the actual cost:benefit of new treatments. #cancer Rare Cancers Australia

#Personcentred care is a term widely used across our #cancer community. But what does this look like in action?
I’ll be exploring this as part of a new Rare Cancers Australia #free #webinar series which looks at the topic from a variety
of perspectives: bit.ly/3vQ24xp